SPONSOR
Chipscreen Biosciences, Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1, Phase 2
NCT06947967 Phase 3
Recruiting
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Lymphoma, T-Cell, Peripheral
NCT07129382 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis